Showing results (81-90 of 154) with videos related to
Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|June 16, 2004
Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinibToshimi Takano, Yuichiro Ohe, Masahiko Kusumoto, et al.Carcinogenesis|August 17, 2004
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokersMasaki Fujieda, Hiroshi Yamazaki, Tetsuya Saito, et al.Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapyShigeo Yamazaki, Ikuo Sekine, Yoshihiro Matsuno, et al.JTO Clinical and Research Reports|May 23, 2022
Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC-Real-World Data in the Era of Molecularly Targeted Agents and ImmunotherapyTakehito Shukuya, Kazuya Takamochi, Hiroyuki Sakurai, et al.Japanese Journal of Clinical Oncology|July 28, 2020
Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE RegistryYasuo Ohashi, Masataka Ikeda, Hideo Kunitoh, et al.Carcinogenesis|November 14, 2008
Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the JapaneseKouya Shiraishi, Takashi Kohno, Hideo Kunitoh, et al.Journal of Oncology Practice|September 3, 2011
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trialChiharu Tanai, Takako Eguchi Nakajima, Kengo Nagashima, et al.International Journal of Clinical Oncology|March 2, 2024
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysisMashio Nakamura, Masato Sakon, Mitsuru Sasako, et al.Molecular and Cellular Biology|April 11, 2013
Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levelsTakafumi Suzuki, Tatsuhiro Shibata, Kai Takaya, et al.Investigational New Drugs|July 13, 2011
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancerYasushi Goto, Ikuo Sekine, Maki Tanioka, et al.Pageof 16